Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Origin and immunophenotype of aberrant IEL in RCDII patients.

Tack GJ, van Wanrooij RL, Langerak AW, Tjon JM, von Blomberg BM, Heideman DA, van Bergen J, Koning F, Bouma G, Mulder CJ, Schreurs MW.

Mol Immunol. 2012 Apr;50(4):262-70. doi: 10.1016/j.molimm.2012.01.014.

PMID:
22364936
2.

Identification of a potential physiological precursor of aberrant cells in refractory coeliac disease type II.

Schmitz F, Tjon JM, Lai Y, Thompson A, Kooy-Winkelaar Y, Lemmers RJ, Verspaget HW, Mearin ML, Staal FJ, Schreurs MW, Cupedo T, Langerak AW, Mulder CJ, van Bergen J, Koning F.

Gut. 2013 Apr;62(4):509-19. doi: 10.1136/gutjnl-2012-302265.

PMID:
22760007
3.

The presence of small intestinal intraepithelial gamma/delta T-lymphocytes is inversely correlated with lymphoma development in refractory celiac disease.

Verbeek WH, von Blomberg BM, Scholten PE, Kuik DJ, Mulder CJ, Schreurs MW.

Am J Gastroenterol. 2008 Dec;103(12):3152-8. doi: 10.1111/j.1572-0241.2008.02213.x.

PMID:
19086962
4.

Dendritic cells promote expansion and survival of aberrant TCR-negative intraepithelial lymphocyte lines from refractory celiac disease type II patients.

Schmitz F, Tjon JM, van Bergen J, Koning F.

Mol Immunol. 2014 Mar;58(1):10-6. doi: 10.1016/j.molimm.2013.10.014.

PMID:
24252355
5.

Optimal strategies to identify aberrant intra-epithelial lymphocytes in refractory coeliac disease.

van Wanrooij RL, Müller DM, Neefjes-Borst EA, Meijer J, Koudstaal LG, Heideman DA, Bontkes HJ, von Blomberg BM, Bouma G, Mulder CJ.

J Clin Immunol. 2014 Oct;34(7):828-35. doi: 10.1007/s10875-014-0075-7.

PMID:
25062848
6.

Aberrant T-lymphocytes in refractory coeliac disease are not strictly confined to a small intestinal intraepithelial localization.

Verbeek WH, von Blomberg BM, Coupe VM, Daum S, Mulder CJ, Schreurs MW.

Cytometry B Clin Cytom. 2009 Nov;76(6):367-74. doi: 10.1002/cyto.b.20481.

7.

Frequency of clonal intraepithelial T lymphocyte proliferations in enteropathy-type intestinal T cell lymphoma, coeliac disease, and refractory sprue.

Daum S, Weiss D, Hummel M, Ullrich R, Heise W, Stein H, Riecken EO, Foss HD; Intestinal Lymphoma Study Group..

Gut. 2001 Dec;49(6):804-12.

8.

Flow cytometric determination of aberrant intra-epithelial lymphocytes predicts T-cell lymphoma development more accurately than T-cell clonality analysis in Refractory Celiac Disease.

Verbeek WH, Goerres MS, von Blomberg BM, Oudejans JJ, Scholten PE, Hadithi M, Al-Toma A, Schreurs MW, Mulder CJ.

Clin Immunol. 2008 Jan;126(1):48-56.

PMID:
18024205
9.

Immunohistochemical and T-cell receptor gene rearrangement analyses as predictors of morbidity and mortality in refractory celiac disease.

Arguelles-Grande C, Brar P, Green PH, Bhagat G.

J Clin Gastroenterol. 2013 Aug;47(7):593-601. doi: 10.1097/MCG.0b013e31828a3c44.

PMID:
23470642
10.

Aberrant extrathymic T cell receptor gene rearrangement in the small intestinal mucosa: a risk factor for coeliac disease?

Bas A, Forsberg G, Sjöberg V, Hammarström S, Hernell O, Hammarström ML.

Gut. 2009 Feb;58(2):189-95. doi: 10.1136/gut.2007.125526.

11.

DNAM-1 mediates epithelial cell-specific cytotoxicity of aberrant intraepithelial lymphocyte lines from refractory celiac disease type II patients.

Tjon JM, Kooy-Winkelaar YM, Tack GJ, Mommaas AM, Schreurs MW, Schilham MW, Mulder CJ, van Bergen J, Koning F.

J Immunol. 2011 Jun 1;186(11):6304-12. doi: 10.4049/jimmunol.1003382.

12.

Mucosal intraepithelial T-lymphocytes in refractory celiac disease: a neoplastic population with a variable CD8 phenotype.

de Mascarel A, Belleannée G, Stanislas S, Merlio C, Parrens M, Laharie D, Dubus P, Merlio JP.

Am J Surg Pathol. 2008 May;32(5):744-51. doi: 10.1097/PAS.0b013e318159b478.

PMID:
18360280
13.

Therapy in RCDII: Rationale for Combination Strategies?

Nijeboer P, Malamut G, Bouma G, Cerf-Bensussan N, Koning F, van Bergen J, Cellier C, Mulder CJ.

Dig Dis. 2015;33(2):227-30. doi: 10.1159/000381076. Review.

PMID:
25925927
14.

Refractory coeliac sprue is a diffuse gastrointestinal disease.

Verkarre V, Asnafi V, Lecomte T, Patey Mariaud-de Serre N, Leborgne M, Grosdidier E, Le Bihan C, Macintyre E, Cellier C, Cerf-Bensussan N, Brousse N.

Gut. 2003 Feb;52(2):205-11.

15.

IL-15 triggers an antiapoptotic pathway in human intraepithelial lymphocytes that is a potential new target in celiac disease-associated inflammation and lymphomagenesis.

Malamut G, El Machhour R, Montcuquet N, Martin-Lannerée S, Dusanter-Fourt I, Verkarre V, Mention JJ, Rahmi G, Kiyono H, Butz EA, Brousse N, Cellier C, Cerf-Bensussan N, Meresse B.

J Clin Invest. 2010 Jun;120(6):2131-43. doi: 10.1172/JCI41344.

16.
17.

Cytokine production by intestinal intraepithelial lymphocyte subsets in celiac disease.

León F, Sánchez L, Camarero C, Roy G.

Dig Dis Sci. 2005 Mar;50(3):593-600.

PMID:
15810648
19.
20.

Phenotypical and functional characterization of small intestinal TcR gamma delta + T cells in coeliac disease.

Rust C, Kooy Y, Peña S, Mearin ML, Kluin P, Koning F.

Scand J Immunol. 1992 Apr;35(4):459-68.

PMID:
1532668

Supplemental Content

Support Center